ATLANTA, GA – MapHabit, an Atlanta-based technology company, has been awarded an additional $2.4 Million Small Business Innovation Research (SBIR) Phase II Grant from the National Institute on Aging, part of the National Institutes of Health (Award Number 2R44AG065081-03A1). The two-year grant will provide funds to support MapHabit’s further development of their award-winning assistive technology platform, designed to help individuals with Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD). The funds will enable us to research and develop key aspects of gamification, social networks and predictive health into our digital health platfrom.Principal Investigator and MapHabit CEO and Co-Founder Matthew Golden stated “We are honored to be awarded a competitive renewal of our successful Phase I grant for further developing Maphabit, which will improve the lives of many individuals living with Alzheimer’s Disease, as well as their families, support partners and healthcare providers.  The capabilities we are developing will better position MapHabit with our existing business partner providers and open up new opportunities with payers and direct to families aging in place.”MapHabit will be working with several healthcare-focused AI companies to develop predictive models that can help identify patterns of behavior when monitoring changes in cognitive health status that will be helpful for clinicians and support partners. Additionally, MapHabit will also work with Virtuleap, a health and education VR company, to seamlessly integrate serious games to increase an individual’s social interaction with others through gamification.About MapHabitMapHabit is an interactive care management, dementia training and cognitive engagement platform based in Atlanta, GA that promotes independence and enhances the quality of life for individuals that need additional cognitive support. Utilizing an integrated, visual mapping system, MapHabit provides key tools to better accomplish their activities of daily living  while providing oversight and peace of mind to their caregivers and family members.For questions, contact Paolo Aguila, Director of Marketing, MapHabit paguila@maphabit.com.About VirtuleapVirtuleap combines neuroscience and virtual reality to help increase attention levels, and address cognitive illnesses, disorders, and learning challenges. Virtuleap has created a library of VR games designed by neuroscientists in order to test and train a range of cognitive abilities and make that data accessible through their enterprise platform. Virtuleap is working with leading institutions, like the VA Health Care System and the Pacific Brain Health Center, to validate their solution as an effective diagnostic and treatment for attention deficit and cognitive decline. For more information, visit www.virtuleap.com.